3-D Matrix Ltd. engages in the research, development, manufacture, and sale of medical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 114 full-time employees. The company went IPO on 2011-10-24. The firm has Medical Product segment. The segment consists of two divisions. The medical product development and sales division is engaged in the research and development of medical equipment and drugs for surgery area, regeneration medicine area and drug delivery system (DDS) area based on the self-organizing peptide technology, including hemostatic, vascular embolization and alveolar bone reconstruction materials, among others. The research reagents sales division is engaged in the sale of medical products based on the self-organizing peptide technology for research and test use in universities and research institutes.
Follow-Up Questions
DMTRF 주식의 가격 성능은 어떻습니까?
DMTRF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
3-D Matrix Ltd의 주요 사업 주제나 업종은 무엇입니까?
3-D Matrix Ltd은 Biotechnology 업종에 속하며, 해당 부문은 Health Care입니다
